Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2019
Operating Activities      
Consolidated net income (loss) $ 255.2 $ (53.4) $ 126.2
Adjustments to reconcile net income (loss) to cash provided by operating activities:      
Depreciation and amortization 115.1 130.6 58.5
Impairment charges 11.2 144.8 0.0
Deferred income taxes 12.2 (19.5) 6.7
Amortization of deferred financing costs 7.2 3.9 6.8
Settlement of interest rate swaps, net 0.0 0.0 (13.8)
Share-based compensation 19.7 14.0 12.0
Settlement of Milacron share-based equity awards 0.0 5.9 0.0
(Gain) loss on divestitures (67.1) 3.5 0.0
Trade receivables and receivables from long-term manufacturing contracts (24.2) 91.7 (66.2)
Inventories (33.4) 58.5 (8.6)
Prepaid expenses and other current assets (1.7) 19.0 (7.6)
Trade accounts payable 91.3 (68.2) 46.4
Liabilities from long-term manufacturing contracts and advances, accrued compensation, and other current liabilities 148.2 (2.5) 36.0
Income taxes payable (5.9) 16.4 (9.6)
Defined benefit plan funding (11.6) (12.4) (10.3)
Defined benefit plan expense 3.1 6.8 3.5
Other, net 9.1 15.7 (1.1)
Net cash provided by operating activities 528.4 354.8 178.9
Investing Activities      
Capital expenditures (40.0) (35.9) (25.5)
Proceeds from sales of property, plant, and equipment 0.2 21.2 0.2
Acquisitions of businesses, net of cash acquired 0.0 (1,503.1) (25.9)
Proceeds from divestitures, net of cash divested 165.8 221.9 0.0
Net cash provided by (used in) investing activities 126.0 (1,295.9) (51.2)
Financing Activities      
Proceeds from long-term debt, net of discount 350.0 1,125.2 374.4
Repayments of long-term debt (688.8) (186.3) 0.0
Proceeds from revolving credit facility 395.0 1,351.7 897.3
Repayments on revolving credit facility (395.0) (1,353.9) (990.4)
Payment of deferred financing costs (5.4) (14.7) (7.5)
Payment of dividends on common stock (64.0) (63.4) (52.6)
Repurchases of common stock (121.1) 0.0 0.0
Proceeds from stock option exercises and other 13.1 1.2 2.6
Payments for employee taxes on net settlement equity awards (3.5) (1.9) (4.2)
Other, net (3.6) (3.0) (2.1)
Net cash (used in) provided by financing activities (523.3) 854.9 217.5
Effect of exchange rate changes on cash and cash equivalents 8.0 (1.4) (2.3)
Net cash flows 139.1 (87.6) 342.9
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]      
At Beginning of Period 311.8 399.4 56.5
At End of Period 450.9 311.8 399.4
Cash paid for interest 63.2 56.7 19.9
Cash paid for income taxes 93.2 39.2 53.3
Cash, cash equivalents, and restricted cash:      
Cash and cash equivalents 446.1 302.2  
Short-term restricted cash included in other current assets 1.3 9.6  
Cash and cash equivalents held for sale 3.5 0.0  
Total cash, cash equivalents, and restricted cash shown in the Consolidated Statements of Cash Flows $ 450.9 $ 311.8 $ 399.4